Compound Evidence File
#EC-2026-0231
Boldenone Cypionate
Filed under Injectable Oils. The bureau holds 175 laboratory returns for this compound from 55 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
55 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 10.0 | 10.0 | 16 May 2026 | 6 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 18 Apr 2026 | 5 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Apr 2026 | 15 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 18 Jan 2026 | 23 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 10.0 | 10.0 | 7 Nov 2025 | 23 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 16 Mar 2026 | 20 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Mar 2026 | 14 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 10.0 | 10.0 | 26 Jan 2026 | 9 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Jan 2026 | 21 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Nov 2025 | 13 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 6 May 2026 | 23 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Apr 2026 | 15 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Jul 2026 | 8 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 10.0 | 10.0 | 15 Dec 2025 | 13 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 2 Feb 2026 | 27 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 10.0 | 10.0 | 10.0 | 27 Apr 2026 | 11 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Feb 2026 | 2 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 9.9 | 14 Jan 2026 | 13 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 10.0 | 7 Dec 2025 | 13 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 21 Apr 2026 | 18 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 9.9 | 13 May 2026 | 27 Jun 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 9.3 | 9.3 | 9.3 | 13 Jun 2025 | 13 Jun 2025 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 9.3 | 9.3 | 9.3 | 17 Dec 2024 | 17 Dec 2024 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 8.9 | 8.9 | 8.9 | 24 Apr 2025 | 24 Apr 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.7 | 7.4 | 10.0 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.7 | 7.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.4 | 6.0 | 9.3 | 25 May 2026 | 25 May 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 8.4 | 7.2 | 9.6 | 7 May 2025 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.3 | 7.8 | 9.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.1 | 7.1 | 9.8 | 21 May 2026 | 21 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 12 | 8.0 | 4.9 | 10.0 | 17 Dec 2024 | 23 May 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 | 21 May 2025 |
| OupeptideCASE #VI-2026-0435 | X | 13 | 7.6 | 4.9 | 10.0 | 9 Jun 2025 | 23 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 7.3 | 6.6 | 8.8 | 20 Jun 2025 | 17 May 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 7.2 | 7.2 | 7.2 | 13 Jun 2025 | 13 Jun 2025 |
| HXNetCASE #VI-2026-0061 | X | 4 | 6.8 | 4.3 | 8.7 | 7 May 2025 | 19 Jan 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 2 | 6.7 | 6.3 | 7.0 | 25 Apr 2025 | 21 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 6 | 6.6 | 5.3 | 9.8 | 7 May 2025 | 21 May 2026 |
| YimeiCASE #VI-2026-0081 | X | 3 | 6.5 | 6.0 | 7.3 | 3 Jul 2025 | 24 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 | 2 Apr 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 6.3 | 6.3 | 6.3 | 11 Jun 2025 | 11 Jun 2025 |
| Alpha-GenCASE #VI-2026-0905 | X | 3 | 5.9 | 5.0 | 7.3 | 28 Mar 2025 | 23 May 2026 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 5.9 | 5.9 | 5.9 | 2 Apr 2025 | 2 Apr 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 5.8 | 4.8 | 6.7 | 16 Mar 2025 | 24 May 2026 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 5.4 | 5.4 | 5.4 | 27 Feb 2025 | 27 Feb 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 4.6 | 4.6 | 4.6 | 17 Dec 2024 | 17 Dec 2024 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 5 | 4.5 | 0.8 | 6.8 | 17 Dec 2024 | 24 May 2026 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 1 | 4.4 | 4.4 | 4.4 | 13 Jun 2025 | 13 Jun 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 3.7 | 3.7 | 3.7 | 2 Apr 2025 | 2 Apr 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 3.4 | 2.5 | 4.2 | 3 Jul 2025 | 25 May 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 2.9 | 2.9 | 2.9 | 21 May 2025 | 21 May 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 2.6 | 2.6 | 2.6 | 8 Jul 2025 | 8 Jul 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
Open any subject to view the batch-level evidence for Boldenone Cypionate alone.